[3614] Vos, S JB., Xiong C., Visser P J., Jasielec M. S., Hassenstab J., Grant E. A., et al. (2013).  Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study. The Lancet Neurology. 12(10), 957 - 965.

[2997] Bateman, R. J., Xiong C., Benzinger T. L. S., Fagan A. M., Goate A., Fox N. C., et al. (2012).  Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease. New England Journal of Medicine. 120723122607004 - 120723122607004.

[2785] Kauwe, J. S. K., Cruchaga C., Karch C. M., Sadler B., Lee M., Mayo K., et al. (2011).  Fine Mapping of Genetic Variants in BIN1, CLU, CR1 and PICALM for Association with Cerebrospinal Fluid Biomarkers for Alzheimer's Disease. PLoS ONE. 6(2), e15918 - e15918.

[1888] Galvin, J. E., Fagan A. M., Holtzman D. M., Mintun M. A., & Morris J. C. (2010).  Relationship of dementia screening tests with biomarkers of Alzheimer’s disease. Brain. 133(11), 3290 - 3300.